M&A Deal Summary |
|
---|---|
Date | 2012-06-04 |
Target | URL Pharma |
Sector | Life Science |
Buyer(s) | Takeda Pharmaceuticals U.S.A. |
Deal Type | Add-on Acquisition |
Deal Value | 800M USD |
Advisor(s) | J.P. Morgan Securities (Financial) Ropes & Gray (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1998 |
Sector | Medical Products |
As a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) is among the top 15 pharmaceutical companies in the United States.Striving toward better health for people worldwide through leading innovation in medicine
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (Pennsylvania) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2012) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2012-12-17 |
URL Pharma
Philadelphia, Pennsylvania, United States URL Pharma, Inc. is a manufacturer of branded and generic medicines. Its core products include Qualaquin, Colcrys, Fibricor, and Bactrim. |
Sell | - |